Cargando…
Mingjing granule, a traditional Chinese medicine in the treatment of neovascular age-related macular degeneration: study protocol for a randomized controlled trial
BACKGROUND: Neovascular age-related macular degeneration (nAMD) is the most common cause of irreversible vision loss and blindness among the older people aged 50 and over. Although anti-vascular endothelial growth factor (anti-VEGF) therapies have resulted in improving patient outcomes, there are li...
Autores principales: | Li, Yamin, Liang, Lina, Snellingen, Torkel, Xu, Kai, Gao, Yun, Zhang, Fengmei, Guo, Chengwei, Zuo, Tao, Liang, Fengming, Yao, Xiaoping, Yang, Xueyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814434/ https://www.ncbi.nlm.nih.gov/pubmed/33468208 http://dx.doi.org/10.1186/s13063-021-05025-x |
Ejemplares similares
-
Apolipoprotein E gene and age-related macular degeneration in a Chinese population
por: Sun, Erdan, et al.
Publicado: (2011) -
Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021) -
Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population
por: Xu, Yule, et al.
Publicado: (2008) -
Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006) -
Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial
por: Foss, Alexander JE, et al.
Publicado: (2015)